References
- Balasubramaniam, S.D., et al., 2019. Key molecular events in cervical cancer development. Medicina, 55 (7), 384.
- Bizzarri, N., et al., 2021. Peritoneal HPV-DNA test in cervical cancer (PIONEER study): a proof of concept. International Journal of Cancer, 148 (5), 1197–1207.
- Bray, F., et al., 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68 (6), 394–424.
- Chai, R.C., et al., 2015. Current trends in the etiology and diagnosis of HPV-related head and neck cancers. Cancer Medicine, 4 (4), 596–607.
- Chen, J., et al., 2019. Prevalence and incidence of human papillomavirus (HPV) infection before and after pregnancy: pooled analysis of the control arms of efficacy trials of HPV-16/18 AS04-adjuvanted vaccine. Open Forum Infectious Diseases, 6 (12), ofz486.
- Chen, Z., et al., 2013. Genotype distribution and the relative risk factors for human papillomavirus in Urumqi, China. Experimental and Therapeutic Medicine, 6 (1), 85–90.
- Donders, G., 2010. Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstetrical & Gynecological Survey, 65 (7), 462–473.
- Donders, G.G.G., et al., 2017. Aerobic vaginitis: no longer a stranger. Research in Microbiology, 168 (9–10), 845–858.
- Donders, G.G., et al., 2002. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG, 109 (1), 34–43.
- Doorbar, J., 2007. Papillomavirus life cycle organization and biomarker selection. Disease Markers, 23 (4), 297–313.
- Dorji, T., et al., 2022. Gender-neutral HPV elimination, cervical cancer screening, and treatment: experience from Bhutan. International Journal of Gynaecology & Obstetrics, 156 (3), 425–429.
- Flatley, J.E., et al., 2014. Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study. BMC Cancer, 14, 803.
- Gillet, E., et al., 2011. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infectious Diseases, 11 (1), 10.
- Gravitt, P.E., 2011. The known unknowns of HPV natural history. Journal of Clinical Investigation, 121 (12), 4593–4599.
- Guo, Y.L., et al., 2012. Bacterial vaginosis is conducive to the persistence of HPV infection. International Journal of STD & AIDS, 23 (8), 581–584.
- Lee, J.E., et al., 2013. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLOS One, 8 (5), e63514.
- Liang, Y., et al., 2019. A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia. Infectious Agents and Cancer, 14, 29.
- Lin, W., et al., 2022. Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis. Scientific Reports, 12 (1), 2812.
- Liu, P., et al., 2017. Targeted, deep sequencing reveals full methylation profiles of multiple HPV types and potential biomarkers for cervical cancer progression. Cancer Epidemiology, Biomarkers & Prevention, 26 (4), 642–650.
- Liu, H., et al., 2022. Association of cervical dysbacteriosis, HPV oncogene expression, and cervical lesion progression. Microbiology Spectrum, 10 (5), e0015122.
- Liu, S., et al., 2018. Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression. PLOS One, 13 (2), e0193061.
- Lyu, Y., et al., 2019. Influencing factors of high-risk human papillomavirus infection and DNA load according to the severity of cervical lesions in female coal mine workers of China. Journal of Cancer, 10 (23), 5764–5769.
- Mariani, L., et al., 2010. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy. BMC Cancer, 10 (1), 259.
- Medeiros, R., et al., 2020. Prevention of human papillomavirus infection. beyond cervical cancer: a brief review. Acta Medica Portuguesa, 33 (3), 198–201.
- Mitra, A., et al., 2016. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome, 4 (1), 58.
- Nugent, R.P., Krohn, M.A., and Hillier, S.L., 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of Clinical Microbiology, 29 (2), 297–301.
- Pandey, P., et al., 2021. Elucidation of rutin’s role in inducing caspase-dependent apoptosis via HPV-E6 and E7 down-regulation in cervical cancer HeLa cells. Bioscience Reports, 41 (6), BSR20210670.
- Parkin, D.M., et al., 2020. Cancer in Africa 2018: the role of infections. International Journal of Cancer, 146 (8), 2089–2103.
- Paskeh, M.D.A., et al., 2021. Cervical cancer progression is regulated by SOX transcription factors: revealing signaling networks and therapeutic strategies. Biomedicine & Pharmacotherapy, 144, 112335.
- Rajaram, S. and Gupta, B., 2022. Screening for cervical cancer: choices & dilemmas. Indian Journal of Medical Research, 154 (2), 210–220.
- Rajendra, S. and Sharma, P., 2019. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy? Diseases of the Esophagus, 32 (7), doz008.
- Rho, S.B., et al., 2020. IRF-1 inhibits angiogenic activity of HPV16 E6 oncoprotein in cervical cancer. International Journal of Molecular Sciences, 21 (20), 7622.
- Rocha-Brischiliari, S.C., et al., 2014. Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women. Infectious Agents and Cancer, 9 (1), 6.
- Ruttkay-Nedecky, B., et al., 2013. Relevance of infection with human papillomavirus: the role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins. International Journal of Oncology, 43 (6), 1754–1762.
- Shen, L., et al., 2022. Vaginal microecological characteristics of women in different physiological and pathological period. Frontiers in Cellular and Infection Microbiology, 12, 959793.
- Sousa, H., et al., 2014. Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer. Tumour Biology, 35 (3), 2561–2564.
- Sui, S., et al., 2019. Correlation of APOBEC3G polymorphism with human papillomavirus (HPV) persistent infection and progression of cervical lesions. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 25, 6990–6997.
- Sun, J., et al., 2021. Detection of HPV E6/E7 mRNA in the diagnosis of cervical cancer and precancerous lesions after kidney transplantation. American Journal of Translational Reseasrch, 13 (6), 7312–7317.
- Teng, P. and Hao, M., 2020. A population-based study of age-related associations between vaginal pH and the development of cervical intraepithelial neoplasia. Cancer Medicine, 9 (5), 1890–1902.
- Tiiti, T.A., et al., 2022. High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa. BMC Cancer, 22 (1), 854.
- Tonhajzerova, I., et al., 2019. Novel biomarkers of early atherosclerotic changes for personalised prevention of cardiovascular disease in cervical cancer and human papillomavirus infection. International Journal of Molecular Sciences, 20 (15), 3720.
- Valenti, G., et al., 2017. Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice? Updates in Surgery, 69 (4), 441–449.
- Vieira-Baptista, P., et al., 2016. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities. European Journal of Clinical Microbiology & Infectious Diseases, 35 (4), 657–664.
- Wei, W., et al., 2022. The role of vaginal microecology in the cervical cancer. Journal of Obstetrics and Gynaecology Research, 48 (9), 2237–2254.
- Zhang, H., et al., 2022. Correlation between vaginal microecological status and prognosis of CIN patients with high-risk HPV infection. Biomed Research International, 2022, 3620232.
- Zhang, Y., et al., 2021. Diagnostic value of vaginal microecology, serum miR-18a, and PD-L1 for identifying HPV-positive cervical cancer. Technology in Cancer Research & Treatment, 20, 1533033821995281.